{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T10:05:04Z","timestamp":1753869904245,"version":"3.41.2"},"reference-count":30,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K08071","JP20K16625"],"award-info":[{"award-number":["JP19K08071","JP20K16625"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["PCN Reports"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This review aimed to clarify whether antimanic agents used in Japan are superior to placebo for the treatment of acute mania, based on reports of randomized controlled trials (RCTs) conducted in Japan and other East Asian countries. A literature search was conducted using the MEDLINE, PubMed, and Ichushi databases from their dates of inception to July 31, 2021, for studies written in English or Japanese with a primary diagnosis of bipolar I disorder, comparing any of the following active drugs to treat acute mania in adults: aripiprazole, carbamazepine, chlorpromazine, haloperidol, lithium, olanzapine, sultopride, timiperone, and zotepine. A random\u2010effects network meta\u2010analysis was performed within a frequentist framework. The quality of each included study was evaluated using the revised Cochrane risk\u2010of\u2010bias tool for randomized trials. The outcomes adopted were the response rate for efficacy and dropout rate for tolerability during 3 weeks from baseline. Eleven RCTs, totaling 1148 participants, were reviewed. The pooled odds ratio (OR) (\u00b195% confidence interval [CI]) was calculated. Timiperone (OR\u2009=\u20094.53, CI 1.09\u201318.80), sultopride (OR\u2009=\u20093.76, CI 1.08\u201313.05), and aripiprazole (OR\u2009=\u20091.99, CI 1.22\u20133.24) were significantly more effective than placebo. Olanzapine (OR\u2009=\u20090.51, CI 0.29\u20130.90) was significantly superior in acceptability to placebo. The results showed no significant differences from placebo for carbamazepine, chlorpromazine, haloperidol, lithium, and olanzapine. These results suggest that noninferiority trials alone cannot always confirm the antimanic drug efficacy and that direct placebo\u2010controlled trials are necessary to verify the antimanic efficacy of the drugs.<\/jats:p>","DOI":"10.1002\/pcn5.60","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T20:47:36Z","timestamp":1669322856000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A systematic review and network meta\u2010analysis of antimanic drugs for the treatment of acute mania used in Japan"],"prefix":"10.1002","volume":"1","author":[{"given":"Kanako","family":"Ishizuka","sequence":"first","affiliation":[{"name":"Health Support Center Nagoya Institute of Technology  Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8427-5639","authenticated-orcid":false,"given":"Toshiya","family":"Inada","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Nagoya University Graduate School of Medicine  Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200018020-00003"},{"key":"e_1_2_12_3_1","unstructured":"Japan Pharmaceutical Manufacturers Association. Information on Japanese regulatory affairs.2020. Accessed September 21 2022. Available from:https:\/\/www.jpma.or.jp\/english\/about\/parj\/eki4g6000000784o-att\/2020e_ch01.pdf\u00a0"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.5234\/cnpt.11.9"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12060"},{"key":"e_1_2_12_6_1","unstructured":"Japanese Society of Mood Disorders. Treatment guideline for bipolar disorders2020. Accessed September 21 2022. Available from:https:\/\/www.secretariat.ne.jp\/jsmd\/iinkai\/katsudou\/data\/guideline_sokyoku2020.pdf\u00a0"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.DMPK-11-RV-111"},{"key":"e_1_2_12_8_1","first-page":"1249","article-title":"Double\u2010blind conparative study on antimanic effects of zotepine and lithium carbonate. Rinsyo Seisin","volume":"23","author":"Harada T","year":"1994","journal-title":"Igaku"},{"key":"e_1_2_12_9_1","first-page":"23","article-title":"Comparison of efficacy of lithium carbonate and chlorpromazine in mania by double\u2010blind controlled study","volume":"2","author":"Takahashi R","year":"1974","journal-title":"Rinsyo\u2010Hyoka"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1058"},{"key":"e_1_2_12_13_1","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna Austria;2020. Accessed September 21 2022. Available from:https:\/\/www.R-project.org\/"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.10.045"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2010.02066.x"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2012.669047"},{"key":"e_1_2_12_18_1","first-page":"15","article-title":"Comparison of therapeutic effect on mania of sultopride hydrochloride with haloperidol using double\u2010blind technique","volume":"15","author":"Kudo Y","year":"1987","journal-title":"Rinsyo\u2010Hyoka"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2007.04.020"},{"key":"e_1_2_12_20_1","first-page":"509","article-title":"Comparison of anti\u2010manic efficacy of carbamazepine and chlorpromazine by double\u2010blind controlled study","volume":"7","author":"Okuma T","year":"1979","journal-title":"Rinsyo\u2010Hyoka"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00428308"},{"key":"e_1_2_12_22_1","first-page":"115","article-title":"Comparison of anti\u2010manic efficacy of carbamazepine and lithium carbonate by double\u2010blined controlled study","volume":"16","author":"Okuma T","year":"1988","journal-title":"Rinsyo\u2010Hyoka"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014497"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760280108010"},{"key":"e_1_2_12_25_1","first-page":"1329","article-title":"Comparison of anti\u2010manic efficacy of timiperone injection and haloperidol injection by double\u2010blind controlled study","volume":"1","author":"Inanaga K","year":"1985","journal-title":"Rinsyo\u2010Iyaku"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3182560401"},{"key":"e_1_2_12_27_1","article-title":"Lithium for acute mania","volume":"6","author":"McKnight RF","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60873-8"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5195"},{"key":"e_1_2_12_30_1","unstructured":"World Health Organization International Clinical Trials Registry Platform (ICTRP). Accessed September 21 2022.\u00a0Available from:https:\/\/www.who.int\/clinical-trials-registry-platform"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30088-4"}],"container-title":["Psychiatry and Clinical Neurosciences Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pcn5.60","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pcn5.60","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pcn5.60","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T06:31:12Z","timestamp":1697178672000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pcn5.60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1002\/pcn5.60"],"URL":"https:\/\/doi.org\/10.1002\/pcn5.60","archive":["Portico"],"relation":{},"ISSN":["2769-2558","2769-2558"],"issn-type":[{"type":"print","value":"2769-2558"},{"type":"electronic","value":"2769-2558"}],"subject":[],"published":{"date-parts":[[2022,11,24]]},"assertion":[{"value":"2022-07-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e60"}}